A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease

JJ Solomon, S Danoff, F Woodhead, S Hurwitz, R Maurer, I Glaspole, PF Dellaripa, B Gooptu, R Vassallo, PG Cox, KR Flaherty, HI Adamali, MA Gibbons, Nazia Chaudhuri, the TRAIL1 Network Investigators

Research output: Contribution to conference › Abstract › peer-review

Fingerprint

Dive into the research topics of 'A Randomized, Double-Blinded, Placebo-Controlled, Phase 2 Study of Safety, Tolerability and Efficacy of Pirfenidone in Patients with Rheumatoid Arthritis Interstitial Lung Disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science